The major US stock indexes opened significantly lower this morning as investors reacted to the surprise loss of $2 billion by JPMorgan Chase & Co. (NYSE: JPM) disclosed by the ... Read Full Story »
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Adtran Inc. (NASDAQ: ADTN) Reiterated Buy and $39 target at Argus. Apple ... Read Full Story »
Facebook’s initial public offering is already oversubscribed. (Reuters) JP Morgan (NYSE: JPM) books a $2 billion trading loss, and the figure could rise by another $1 billion. (Reuters) China’s industrial ... Read Full Story »
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Wednesday. American International Group, Inc. (NYSE: AIG) Raised to Buy at Goldman ... Read Full Story »
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech ... Read Full Story »
VIVUS Inc. (NASDAQ: VVUS) is getting a bit of a haircut this morning on the heels of some news from the Food & Drug Administration which may throw up some ... Read Full Story »
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday. Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) Cut to Neutral at Piper Jaffray. ... Read Full Story »
Markets opened about higher this morning following a flat close in Asia and a bit of enthusiasm in Europe following a manufacturing survey from Germany (our coverage here). Then Fed ... Read Full Story »
Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) announced that its application to sell its lorcaserin weight-loss drug in Europe has been accepted by the Europe Medicines Agency. This is the ... Read Full Story »
VIVUS, Inc. (NASDAQ: VVUS) is going to likely have a huge day on Thursday. The FDA panel reviewing its Qnexa drug to treat obesity has voted overwhelmingly to offer FDA panel backing ... Read Full Story »
VIVUS, Inc. (NASDAQ: VVUS) is in the news this morning after entering into an agreements with a select group of institutional investors to sell 6,889,098 shares of its common ... Read Full Story »
VIVUS Inc. (NASDAQ: VVUS) was recently shown as one of our five biotechs with 50% upside and news this morning is showing why VIVUS may be one of the only ... Read Full Story »
Friday was a sea of red in the markets, but earnings season creates many winners and losers. This last week brought on another interesting aspect: Many Stocks Got Hammered! It ... Read Full Story »
Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of Applied Signal Technology, Inc. (NASDAQ: APSG), Arena ... Read Full Story »
There are many stocks on the move this Monday morning for active traders. Stocks we are tracking are Apple Inc. (NASDAQ: AAPL), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Expedia Inc. (NASDAQ: ... Read Full Story »